Montelukast (singulair) for allergic rhinitis.
D000085:Acetates / Q000494:pharmacology / Q000627:therapeutic use*; D000281:Administration, Intranasal; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D003521:Cyclopropanes; D004311:Double-Blind Method; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D007408:Intestinal Absorption / Q000187:drug effects; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D013440:Sulfides
D000085:Acetates; D000305:Adrenal Cortex Hormones; D003521:Cyclopropanes; D018836:Inflammation Mediators; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast